Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy.

MLA

Wu, Xiaoning, et al. “Prediction of Liver-Related Events in Patients with Compensated HBV-Induced Cirrhosis Receiving Antiviral Therapy.” Hepatology International, vol. 15, no. 1, Feb. 2021, pp. 82–92. EBSCOhost, https://doi.org/10.1007/s12072-020-10114-1.

APA

Wu, X., Zhou, J., Sun, Y., Ding, H., Chen, G., Xie, W., Piao, H., Xu, X., Jiang, W., Ma, H., Ma, A., Chen, Y., Xu, M., Cheng, J., Xu, Y., Meng, T., Wang, B., Chen, S., Shi, Y., & Kong, Y. (2021). Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy. Hepatology International, 15(1), 82–92. https://doi.org/10.1007/s12072-020-10114-1

Chicago

Wu, Xiaoning, Jialing Zhou, Yameng Sun, Huiguo Ding, Guofeng Chen, Wen Xie, Hongxin Piao, et al. 2021. “Prediction of Liver-Related Events in Patients with Compensated HBV-Induced Cirrhosis Receiving Antiviral Therapy.” Hepatology International 15 (1): 82–92. doi:10.1007/s12072-020-10114-1.